| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8715731 | Journal of Dermatological Science | 2017 | 10 Pages |
Abstract
Inhibition of select MAPK signaling pathways can reverse or potentiate anti-fibrotic FGF2 effects on human dermal fibroblasts, as well as exert their effects independently of exogenous FGF2 supplementation.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
David M. Dolivo, Sara A. Larson, Tanja Dominko,